当前位置: 首页 > 期刊 > 《中外医学研究》 > 2014年第1期
编号:13143318
原发性中枢神经系统淋巴瘤的临床特点及其治疗观察(2)
http://www.100md.com 2014年1月5日 《中外医学研究》 2014年第1期
     [2]Chimienti E,Spina M,Vaccher E,et al.Management of immunocompetent patients with primary central nervous system lymphoma[J].Clin Lymphoms Myeloma,2009,9(5):353-364.

    [3]曹国斌,柯炎斌,何伟文,等.原发性颅内淋巴瘤的临床特点及其治疗探讨[J].广东医学,2009,30(7):1120.

    [4]Usui N,Dobashi N,Yano S,et al.High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients-a retrospective study in a single institute[J].Gan to Kagaku Ryoho,2010,37(7):1277-1282.

    [5]Shibamoto Y,Ogino H,Suzuki G,et al.Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during,1985-2004[J].Neuro Oncol,2008,10(4):560-568.

    [6]Norden A D,Drappatz J,Wen P Y,et al.Survival among patients with primary central nervous system lymphoma,1973-2004[J].J Neuroomcol,2011,101(3):487-493.

    [7]Juergens A,Pals H,Rogowaki S,et al.Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma[J].Ann Neurol,2010,67(2):182-189.

    [8]Campen C J,Tombleson R L,Green M R.High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma[J].J Neurooncol,2011,101(3):345-355.

    (收稿日期:2013-09-28) (编辑:程旭然), http://www.100md.com(王凯娜 张文龙)
上一页1 2